Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
CASI Pharmaceuticals
company
About
CASI focus on building a pipeline through mutually beneficial business development transactions.
- 101 - 250
Highlights
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $50M
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 1991
- Number Of Employee
- 101 - 250
- Operating Status
- Active
CASI Pharmaceuticals, Inc. ("CASI", "we" or "us") is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. CASI is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. CASI is executing its plan to become a biopharmaceutical leader by launching medicines in the greater China market leveraging CASI's China-based regulatory and commercial competencies and its global drug development expertise.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$50M
CASI Pharmaceuticals has raised a total of
$50M
in funding over 2 rounds. Their latest funding was raised on
Mar 20, 2018 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 20, 2018 | Post-IPO Equity | $50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
CASI Pharmaceuticals is funded by 1 investors.
ETP Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
